Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1205

Related search